Gene Therapy for Primary Immunodeficiency

12Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Over the past 3 decades, there has been significant progress in refining gene therapy technologies and procedures. Transduction of hematopoietic stem cells ex vivo using lentiviral vectors can now create a highly effective therapeutic product, capable of reconstituting many different immune system dysfunctions when reinfused into patients. Here, we review the key developments in the gene therapy landscape for primary immune deficiency, from an experimental therapy where clinical efficacy was marred by adverse events, to a commercialized product with enhanced safety and efficacy. We also discuss progress being made in preclinical studies for challenging disease targets and emerging gene editing technologies that are showing promising results, particularly for conditions where gene regulation is important for efficacy.

References Powered by Scopus

A third-generation lentivirus vector with a conditional packaging system

2572Citations
N/AReaders
Get full text

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

1592Citations
N/AReaders
Get full text

HIV-1 integration in the human genome favors active genes and local hotspots

1518Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Future of Therapy for Inborn Errors of Immunity

24Citations
N/AReaders
Get full text

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy

8Citations
N/AReaders
Get full text

Bioprocess monitoring and control: challenges in cell and gene therapy

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Houghton, B. C., & Booth, C. (2021, January 29). Gene Therapy for Primary Immunodeficiency. HemaSphere. Wolters Kluwer Health. https://doi.org/10.1097/HS9.0000000000000509

Readers over time

‘10‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

48%

Researcher 12

36%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

49%

Biochemistry, Genetics and Molecular Bi... 13

29%

Agricultural and Biological Sciences 8

18%

Pharmacology, Toxicology and Pharmaceut... 2

4%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 48

Save time finding and organizing research with Mendeley

Sign up for free
0